Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04459650 · ClinicalTrials.gov registry record · Early Phase 1
A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer
A Early Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT04459650: Completed Early Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04459650 is a Early Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04459650, a Early Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Participants who enroll in this study will undergo the platelet-rich plasma (PRP) study treatment. Participants will have a sample of blood collected and the platelets will be separated and then injected into half of the participants' scalp every 4 weeks for 12 weeks.
Interventions
- PROCEDURE Platelet Rich Plasma system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2025-08-14 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04459650
The ClinicalTrials.gov registry entry for NCT04459650 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet Rich Plasma system is the first listed.
NCT04459650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04459650 about?
NCT04459650 is a clinical study titled "A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer". Participants who enroll in this study will undergo the platelet-rich plasma (PRP) study treatment. Participants will have a sample of blood collected and the platelets will be separated and then injected into half of the participants' scalp every 4 weeks for 12 weeks.
What is the current status of trial NCT04459650?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2020-06-23. Estimated completion is 2025-08-14.
What interventions are being tested in trial NCT04459650?
The interventions under investigation include: Platelet Rich Plasma system (PROCEDURE).
Who is sponsoring clinical trial NCT04459650?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.